4.6 Letter

Clinical predictors of COVID-19 severity and bleeding in the ACTIV-4B COVID-19 outpatient thrombosis prevention trial

Journal

AMERICAN JOURNAL OF HEMATOLOGY
Volume 97, Issue 7, Pages E235-E240

Publisher

WILEY
DOI: 10.1002/ajh.26553

Keywords

-

Categories

Funding

  1. National Institutes of Health (NIH) [1OT2HL156812-01]
  2. National Heart, Lung, and Blood Institute, Bethesda, MD
  3. University of Pittsburgh, Pittsburgh PA
  4. University of Illinois Chicago, Chicago IL
  5. Brigham and Women's Hospital, Boston, MA

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available